Target Price | $344.50 |
Price | $251.08 |
Potential | 37.21% |
Number of Estimates | 28 |
28 Analysts have issued a price target Lululemon Athletica 2026 . The average Lululemon Athletica target price is $344.50. This is 37.21% higher than the current stock price. The highest price target is $500.00 99.14% , the lowest is $194.00 22.73% . | |
A rating was issued by 35 analysts: 20 Analysts recommend Lululemon Athletica to buy, 12 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Lululemon Athletica stock has an average upside potential 2026 of 37.21% . Most analysts recommend the Lululemon Athletica stock at Purchase. |
30 Analysts have issued a sales forecast Lululemon Athletica 2026 . The average Lululemon Athletica sales estimate is $11.2b . This is 6.10% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $11.5b 8.61% , the lowest is $10.4b 1.31% .
This results in the following potential growth metrics:
2025 | $10.6b | 10.07% |
---|---|---|
2026 | $11.2b | 6.10% |
2027 | $12.1b | 7.53% |
2028 | $12.8b | 5.76% |
2029 | $13.8b | 7.69% |
2030 | $14.8b | 7.33% |
25 Analysts have issued an Lululemon Athletica EBITDA forecast 2026. The average Lululemon Athletica EBITDA estimate is $3.0b . This is 0.00% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.2b 6.54% , the lowest is $2.5b 17.01% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $2.9b | 13.89% |
---|---|---|
2026 | $3.0b | 2.09% |
2027 | $3.2b | 6.21% |
2028 | $3.4b | 6.34% |
2029 | $3.8b | 10.87% |
2030 | $4.1b | 9.92% |
2025 | 27.83% | 3.47% |
---|---|---|
2026 | 26.77% | 3.80% |
2027 | 26.44% | 1.23% |
2028 | 26.59% | 0.57% |
2029 | 27.37% | 2.93% |
2030 | 28.03% | 2.41% |
12 Lululemon Athletica Analysts have issued a net profit forecast 2026. The average Lululemon Athletica net profit estimate is $1.8b . This is 2.05% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.9b 6.78% , the lowest is $1.6b 11.00% .
This results in the following potential growth metrics and future Net Margins:
2025 | $1.8b | 20.00% |
---|---|---|
2026 | $1.8b | 2.68% |
2027 | $2.0b | 9.50% |
2028 | $2.1b | 3.09% |
2029 | $2.6b | 27.76% |
2030 | $2.9b | 11.25% |
2025 | 16.77% | 9.02% |
---|---|---|
2026 | 16.23% | 3.22% |
2027 | 16.53% | 1.85% |
2028 | 16.11% | 2.54% |
2029 | 19.11% | 18.62% |
2030 | 19.81% | 3.66% |
12 Analysts have issued a Lululemon Athletica forecast for earnings per share. The average Lululemon Athletica EPS is $15.03 . This is 2.04% higher than earnings per share in the financial year 2025. The highest EPS forecast is $15.73 6.79% , the lowest is $13.11 11.00% .
This results in the following potential growth metrics and future valuations:
2025 | $14.64 | 20.00% |
---|---|---|
2026 | $15.03 | 2.66% |
2027 | $16.46 | 9.51% |
2028 | $16.97 | 3.10% |
2029 | $21.68 | 27.75% |
2030 | $24.12 | 11.25% |
Current | 17.05 | 38.07% |
---|---|---|
2026 | 16.70 | 2.05% |
2027 | 15.25 | 8.68% |
2028 | 14.80 | 2.95% |
2029 | 11.58 | 21.76% |
2030 | 10.41 | 10.10% |
Based on analysts' sales estimates for 2026, the Lululemon Athletica stock is valued at an EV/Sales of 2.66 and an P/S ratio of 2.70 .
This results in the following potential growth metrics and future valuations:
Current | 2.82 | 34.72% |
---|---|---|
2026 | 2.66 | 5.68% |
2027 | 2.47 | 7.01% |
2028 | 2.34 | 5.45% |
2029 | 2.17 | 7.14% |
2030 | 2.02 | 6.83% |
Current | 2.86 | 35.03% |
---|---|---|
2026 | 2.70 | 5.75% |
2027 | 2.51 | 7.01% |
2028 | 2.37 | 5.45% |
2029 | 2.20 | 7.15% |
2030 | 2.05 | 6.83% |
Lululemon Athletica...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 14 2025 |
Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Apr 11 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Apr 10 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Apr 09 2025 |
Baird |
Outperform
➜
Outperform
|
Unchanged | Apr 04 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 28 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 28 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 14 2025 |
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Apr 11 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Apr 10 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Apr 09 2025 |
Unchanged
Baird:
Outperform
➜
Outperform
|
Apr 04 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Mar 28 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Mar 28 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.